Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial OperationsByAndy Studna, Senior EditorAugust 20th 2026
Where AI Has the Most Immediate Impact in Phase I ExecutionByAmber Hill, PhD,Andy Studna, Senior EditorAugust 20th 2026
ACT Brief: AI Architecture and Model Ownership Due Diligence, FDA Framework for Generative AI Medical Devices, and Heidi Overton Nominated for FDA CommissionerByAndy Studna, Senior EditorAugust 20th 2026
FDA Seeks Public Input on Regulatory Framework for Generative AI-Enabled Medical DevicesByAndy Studna, Senior EditorAugust 19th 2026
How to Accelerate Trial Timelines Without Compromising Safety or Data QualityByAmber Hill, PhD,Andy Studna, Senior EditorAugust 19th 2026
